BackLivongo Health Overview
Livongo Health, Inc.

Livongo Health Return on Equity

Valuation check: LVGO's ROE is -5.74%, below the Technology sector average of 47.9%.

Get informed when a big investor buys or sells

+ Follow

ROE

-5.74%

Return on Equity

-5.74%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Livongo Health (LVGO) FAQ

Livongo Health (LVGO) currently reports a ROE of -5.74%. That is below the Technology sector average of 47.9%. Use the charts on this page to explore Livongo Health's ROE history and peer comparisons.

Livongo Health's ROE of -5.74% is lower than the Technology sector average of 47.9%. That is roughly 112.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Livongo Health's current -5.74% should be judged against Technology norms (sector average: 47.9%) and against LVGO's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -5.74%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Technology average is 47.9%. From there, open related valuation or income-statement pages for Livongo Health, and consider following LVGO for alerts when major investors trade the stock.

Livongo Health is classified in the Technology sector. On ROE, it currently shows -5.74% versus a sector average near 47.9%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing LVGO with unrelated industries.